🧬 Coming soon: Rapid Microbial Screen.Sterility screening results in hours, not 14 days.Get notified →
PuriLab Analytical
COA/TZ-2026-079Verified
Save as PDF

Certificate of Analysis

PuriLab Analytical

Tirzepatide 40 mg

TZ-2026-079Lot PMBGB2Analyzed November 20, 2026
Tirzepatide 40 mg vial as received

Timeline

Ordered
November 16, 2026
Received
November 19, 2026
Analyzed
November 20, 2026

Sample

Name
Tirzepatide 40 mg
Expected
Tirzepatide
Amount
1 vial, lyophilized powder

Testing

Client
P.M.B Group
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
37.01mg
Label claim: 40 mg
Purity, how clean it is
97.8%
Measured, not estimated. Purity is calculated from the full chromatogram shown above.

Chromatogram

HPLC-UV

mAU-10001002003004005006007008000481216202428Retention time (min)14.32
14.32 min, Tirzepatide, 97.8%

Analyst Comments

White lyophilized powder, blue-cap vial, received sealed.

Analyst Signature

Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026

Verification Code

TZ-I8Q7-R1EK
Verify at purilab.org/verify/TZ-I8Q7-R1EK

Scan to Verify

TZ-I8Q7-R1EK

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analyticaladmin@purilab.org
Page 1 of 1